INMB - INmune Bio - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $11.9. This is a potential upside of $7.03 (144.35%) from yesterday's end of day stock price of $4.87.

INmune Bio's activity chart (see below) currently has 7 price targets and 4 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 33.33% with an average time for these price targets to be met of 214.67 days.

Most recent stock forecast was given by MAYANK MAMTANI from on 24-May-2022. First documented stock forecast 29-Jan-2021.

Best performing analysts who are covering INMB - INmune Bio:

Chad Mabry Mayank Mamtani Thomas Shrader

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$7

$2.13 (43.74%)

$20

2 years 5 months 30 days ago
(24-May-2022)

1/2 (50%)

$1.52 (27.74%)

13

Buy

$14

$9.13 (187.47%)

$31

2 years 5 months 30 days ago
(24-May-2022)

1/2 (50%)

$8.52 (155.47%)

631

Buy

$34

$23.48 (223.19%)

$29

3 years 4 months 10 days ago
(14-Jul-2021)

0/2 (0%)

$11.04 (48.08%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is INMB (INmune Bio) average time for price targets to be met?

On average it took 214.67 days on average for the stock forecasts to be realized with a an average price target met ratio 33.33

Which analyst has the current highest performing score on INMB (INmune Bio) with a proven track record?

CHAD MABRY

Which analyst has the current lower performing score on INMB (INmune Bio) with a proven track record?

THOMAS SHRADER

Which analyst has the most public recommendations on INMB (INmune Bio)?

Chad Mabry has 11 price targets and 7 ratings on INMB

Which analyst is the currently most bullish on INMB (INmune Bio)?

Chad Mabry with highest potential upside - $23.48

Which analyst is the currently most reserved on INMB (INmune Bio)?

Mayank Mamtani with lowest potential downside - $2.13

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?